Overexpression of PRL and/or PRLR were also described in glioblastoma [6], gynecological cancers [7–9], prostate cancer [10] among other tumor types, reinforcing the notion of PRL:PRLR axis as a broad neoplastic feature providing proliferation and/or survival signaling. This evidence concerns the gene PRL and female reproductive organ cancer.